Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

Research output: Contribution to journalArticlepeer-review

Standard

Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study. / Sabine, V. S.; Crozier, C.; Brookes, C. L.; Drake, C.; Piper, T.; Van De Velde, C. J. H.; Hasenburg, A.; Kieback, D. G.; Markopoulos, C.; Dirix, L.; Seynaeve, C.; Rea, D. W.; Bartlett, John M. S.

In: Journal of Clinical Oncology, Vol. 32, No. 27, 20.09.2014, p. 2951-2958.

Research output: Contribution to journalArticlepeer-review

Harvard

Sabine, VS, Crozier, C, Brookes, CL, Drake, C, Piper, T, Van De Velde, CJH, Hasenburg, A, Kieback, DG, Markopoulos, C, Dirix, L, Seynaeve, C, Rea, DW & Bartlett, JMS 2014, 'Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study', Journal of Clinical Oncology, vol. 32, no. 27, pp. 2951-2958. https://doi.org/10.1200/JCO.2013.53.8272

APA

Sabine, V. S., Crozier, C., Brookes, C. L., Drake, C., Piper, T., Van De Velde, C. J. H., Hasenburg, A., Kieback, D. G., Markopoulos, C., Dirix, L., Seynaeve, C., Rea, D. W., & Bartlett, J. M. S. (2014). Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study. Journal of Clinical Oncology, 32(27), 2951-2958. https://doi.org/10.1200/JCO.2013.53.8272

Vancouver

Author

Sabine, V. S. ; Crozier, C. ; Brookes, C. L. ; Drake, C. ; Piper, T. ; Van De Velde, C. J. H. ; Hasenburg, A. ; Kieback, D. G. ; Markopoulos, C. ; Dirix, L. ; Seynaeve, C. ; Rea, D. W. ; Bartlett, John M. S. / Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study. In: Journal of Clinical Oncology. 2014 ; Vol. 32, No. 27. pp. 2951-2958.

Bibtex

@article{f9999653156541d4885b7cefcf9aa481,
title = "Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study",
author = "Sabine, {V. S.} and C. Crozier and Brookes, {C. L.} and C. Drake and T. Piper and {Van De Velde}, {C. J. H.} and A. Hasenburg and Kieback, {D. G.} and C. Markopoulos and L. Dirix and C. Seynaeve and Rea, {D. W.} and Bartlett, {John M. S.}",
year = "2014",
month = sep,
day = "20",
doi = "10.1200/JCO.2013.53.8272",
language = "English",
volume = "32",
pages = "2951--2958",
journal = "Journal of Clinical Oncology ",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "27",

}

RIS

TY - JOUR

T1 - Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

AU - Sabine, V. S.

AU - Crozier, C.

AU - Brookes, C. L.

AU - Drake, C.

AU - Piper, T.

AU - Van De Velde, C. J. H.

AU - Hasenburg, A.

AU - Kieback, D. G.

AU - Markopoulos, C.

AU - Dirix, L.

AU - Seynaeve, C.

AU - Rea, D. W.

AU - Bartlett, John M. S.

PY - 2014/9/20

Y1 - 2014/9/20

U2 - 10.1200/JCO.2013.53.8272

DO - 10.1200/JCO.2013.53.8272

M3 - Article

VL - 32

SP - 2951

EP - 2958

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 27

ER -